Integrating disparate data sources

Leveraging layers of independent data


Data pervades everything from diagnosis to treatment. Data aggregation and standardization enable deep clinical insights that support prompt, personalized decisions for patients.

Integrating disparate data sources

Leveraging layers of independent data


Data pervades everything from diagnosis to treatment. Data aggregation and standardization enable deep clinical insights that support prompt, personalized decisions for patients.

An unfathomable, exponential growth rate

Integrating data drives efficiency in clinical decision-making and fuels analytics that can present new insights to the best possible patient treatments. Access to aggregated data from disparate sources drives the efficiency of a multidisciplinary team and its tumor board meetings. It is this efficiency that can improve clinician experience while reducing healthcare resource utilization.

NAVIFY® Infographic: Reduced tumor board prep time and addressing interoperability challenges in cancer care

Clinical decision support tools

Clinical decision support (CDS) tools using integrated data platforms can transform healthcare with:

  • A comprehensive view of each patient
  • Support for personalized patient care
  • Enablement of treatment decisions based on the availability of all relevant data, including the latest medical knowledge, clinical practice guidelines and enrolling clinical trials
  • A lower cognitive burden on clinicians
  • Improved healthcare resource utilization through reduction of manual processes, error corrections, unnecessary procedures and ineffective therapies4

What matters most

Aggregated, structured data allows clinicians to shift their focus to the patient.

Systems interoperability and integrated data can translate into more detailed discussions, more collaborative decisions and more patients reviewed.

For patients, this means timely determinations about their care, more targeted therapy and hope during one of the most crucial moments in their lives.

While the promise of CDS is great, it is dependent on the technology solution, the data powering it and effective implementation in the clinical workflow.

56

say unstructured data is a key obstacle to improved systems interoperability2

66

of unstructured data is not accessible for patient care decisions2

Disparate data sources

Several sources of clinical and non-clinical data may be leveraged to inform CDS output. These include:

  • Clinical practice guidelines and pathways
  • Clinical trial data
  • Original research
  • Patient-specific information (e.g., electronic medical records data, imaging data from picture archiving communication systems, genomic data, patient-reported outcomes)
  • Population-level information (e.g., efficiency, quality of care)
  • New and emerging diagnostics (e.g., digital clinical outcomes assessment, ctDNA testing)
  • Treatment information
  • Reimbursement information

An unprecedented opportunity

With the capture and integration of today’s data, we can personalize care in new ways. The convergence of medicine and technology enables a deeper understanding of how to treat individual patients.

NAVIFY Tumor Board links lab results and all other relevant patient information for review, discussion and treatment decision-making in multidisciplinary team meetings. The outcome is what patients need: the right treatment at the right time.

Richard Hammer, MD

To make the best treatment decision, we have to apply the latest medical knowledge to a patient’s medical history, personal preferences and circumstances, test results, images, reports and other information. NAVIFY [Decision Support portfolio] elevates our efficiency and confidence by aggregating these resources.

Richard Hammer, MD
Vice-Chair of Pathology, University of Missouri

NAVIFY® Infographic: Customer oncology CDS maturity levels

Explore
more

Partial image of

Co-developing and co-implementing a digital tumor board solution5

Read more

Partial cover image of NAVIFY brochure about implementation

NAVIFY Decision Support portfolio implementation, integration and support

Read more

Image of a clinician in a face mask in the foreground and other clinicians in the background

Clinical decision support for multidisciplinary cancer care

Read more

  1. Fowler, D., et al. (2020) ‘The Impact Of A Digital Solution On Tumor Board Preparation Time For Pathology Residents’, USCAP.
  2. Hyland Healthcare. (2019) ‘Connected Care and the State of Interoperability in Healthcare’, HIMSS Media.
  3. Oncology Roundtable. (2019) ‘Highlights from the 2018 Trending Now in Cancer Care Survey’, Association of Community Cancer Centers.
  4. Hammer, R. D., et al. (2021) ‘A digital tumor board solution impacts case discussion time and postponement of cases in tumor boards’, Health Technol. https://doi.org/10.1007/s12553-021-00533-x
  5. Hammer, R. D. and Prime, M. S. (2020) ‘A clinician’s perspective on co-developing and co-implementing a digital tumor board solution’, Health Informatics Journal, 26(3), p2213-2221.